Science
General-purpose AI trained solely on clinical reports, without human annotation AUCs of up to 0.984 in pathology assessments of four cancers

A study found that artificial intelligence (AI), working with physicians, increased sensitivity in reading abdominal CT scans by about 10%.
According to BioOn on the 29th (local time), researchers developed RADAR, a general-purpose abdominal CT diagnostic AI trained solely on large-scale clinical reports, without manual human annotation.
The model is based on a scalable vision-language framework and was trained by dividing CT images into anatomical units and aligning them with diagnostic text reports.
Researchers built a large dataset, RAD-CT, comprising 424,911 examinations and 15 million anatomical pairs, to train the model.
In an evaluation of 18 anatomical structures and 146 imaging findings, RADAR recorded an area under the receiver operating characteristic curve (AUC) of 0.913 for diagnosing the 146 findings in a real-world internal cohort of 39,160 cases.
At eight external institutions, AUCs ranged from 0.874 to 0.912. In pathology-confirmed assessments of four cancers—liver, pancreatic, gastric and colorectal cancer—AUCs ranged from 0.891 to 0.984.
RADAR maintained an AUC of 0.904 for acute abdominal conditions excluded from initial training, demonstrating generalization to unfamiliar emergency situations.
In a reading study involving 26 radiologists from 14 institutions, RADAR outperformed most participants and increased sensitivity by about 10% when used collaboratively.
RADAR also provides attention maps that highlight diagnostic visual cues to help interpret readings.
The researchers said, “This study shows that large-scale vision-language learning could offer a feasible path to developing general-purpose AI systems for complex and diverse radiology readings.”
The findings were published in the international journal Science.

BIOBOOK TEAM
biobookmedia@biobook.co.kr
Roche and Zealand’s Amylin Drug Shows Limited Glucose-Lowering Effect, Potentially Narrowing Its Role to Maintenance Therapy

HLB Makes Fourth Attempt to Win Liver Cancer Drug Approval; Manufacturing Inspection Risks Remain

HLB Submits FDA Resubmission for Liver Cancer First-Line Treatment

Nature Cell Wins First-Instance Ruling on Jointstem … “Order for Reconsideration, Not Approval”

Biohub’s $2.4 Billion ‘Virtual Cell’ Project Gives Big Tech 1-Year Exclusive Data Access

Korean Biotechs Target DMOADs for Cartilage Regeneration in Race for Global First
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th